Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 2 Hydroxyphenylacetic Aciduria C5937087
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 2 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
2 Hydroxyphenylacetic Aciduria C5937087
A rare metabolic disorder where the body cannot properly process certain acids. It may cause neurological issues and is typically identified in infancy. Management involves diet modifications and supportive care.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
2 Hydroxyphenylacetic Aciduria C5937087
0-null
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
2 Hydroxyphenylacetic Aciduria C5937087
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
2 Hydroxyphenylacetic Aciduria C5937087
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
2 Hydroxyphenylacetic Aciduria C5937087
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 2-hydroxyphenylacetic-aciduria-C5937087 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 2 Hydroxyphenylacetic Aciduria C5937087 | Discriminating power |
|---|---|---|---|
| Genital or salt-balance features | May include ambiguous genitalia or salt-wasting crisis in severe forms. | Not established as a typical feature from the supplied description. | High |
| Neurological concerns | Not the primary described feature, although severe illness can affect alertness. | Neurological issues may occur, but specific symptoms are not established. | Moderate |
| Growth pattern | Growth issues may occur with hormonal imbalance. | Growth effects are not established in the supplied source. | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Newborn with genital ambiguity or suspected adrenal crisis
The description specifically links this endocrine disorder to cortisol deficiency and salt wasting.
High
Abnormal adrenal steroid pattern
Hormone imbalance is central, but exact cutoffs are not supplied and need specialist review.
Moderate
Lifelong endocrine follow-up is anticipated
The source describes chronic disease managed with hormone replacement.
High
Choose 2 Hydroxyphenylacetic Aciduria C5937087 when
Infant with an abnormal organic-acid result
The source describes identification in infancy, but the result alone does not confirm disease.
Moderate
Neurological symptoms with a metabolic clue
Neurological issues are mentioned, although their pattern is not established.
Low
Need for dietary and supportive metabolic care
Management is described as diet modification and supportive care rather than adrenal replacement.
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 2 Hydroxyphenylacetic Aciduria C5937087 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | Pattern suggesting cortisol deficiency and related hormone imbalance may be sought. | No characteristic adrenal steroid abnormality is established. | Specialist interpretation is required; no cutoff is supplied. |
| Urine organic-acid analysis | Not described as the primary diagnostic test. | May show 2-hydroxyphenylacetic acid elevation, but confirmation is not established here. | Treat an abnormal value as a finding pending clinical correlation. |
| Electrolytes during illness | Salt wasting may cause clinically important electrolyte disturbance. | A specific electrolyte pattern is not established. | Urgent assessment is needed for dehydration or altered consciousness. |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic severe endocrine disorder; outcomes vary and are not quantified here.
- Factors
- Severity, salt wasting, timely treatment, and adherence may matter.
2 Hydroxyphenylacetic Aciduria C5937087
- Outcome
- Course is not established; described severity is moderate.
- Factors
- Neurological involvement and response to supportive care may matter.
Time frame: Both are described as chronic, often recognized early; exact onset is not supplied.
No mortality or prevalence figures should be inferred from these sources.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute crisis | Salt-wasting crisis is a described severe risk. An equivalent crisis pattern is not established. Emergency care is warranted for vomiting, lethargy, or collapse. |
| Neurological effects | Not a defining complication in the source. Neurological issues may occur, with details unspecified. Developmental concerns need individualized evaluation. |
| Treatment burden | Lifelong hormone replacement is described. Diet changes and supportive care are described. Neither source provides doses or outcome rates. |
Patient education highlights
- HighEmergency warning signs
Seek urgent care for poor feeding, vomiting, lethargy, dehydration, or collapse.
- HighResult versus diagnosis
An abnormal laboratory finding needs confirmation and does not by itself establish either condition.
- MediumLong-term care
Ask the clinician about endocrine follow-up, metabolic review, diet, and family implications.